EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
    4.1.1.17 | -999 |
- |
- |
3999, 4000, 4009, 4020, 4023, 4029, 4037 |
| 4.1.1.17 | -999 |
- |
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell viability assay |
681869 |
| 4.1.1.17 | -999 |
- |
activities in cell suspension cultures, overview |
698225 |
| 4.1.1.17 | -999 |
- |
activity in patients with colorectal adenoma and adenocarcinoma, overview |
679273 |
| 4.1.1.17 | -999 |
- |
altered nitric oxide synthase, arginase and ornithine decarboxylase activities, and polyamine synthesis in response to ischemia of the rabbit detrusor, polyamine levels in ischemic detrusor tissue, overview |
681667 |
| 4.1.1.17 | -999 |
- |
assay for enzyme activity based on atmospheric pressure chemical ionization-mass spectrometry of dansylated putrescine |
663622 |
| 4.1.1.17 | -999 |
- |
assay to quantify enzyme levels in formalin-fixed tumor tissues based on antibody coupled to Alexa 647 dye |
665901 |
| 4.1.1.17 | -999 |
- |
circadian variations in ODC activity in female and male mice, overview |
677464 |
| 4.1.1.17 | -999 |
- |
immunohistochemical assay of ODC protein in gastric precancerous and cancerous lesions, overview |
682982 |
| 4.1.1.17 | -999 |
- |
less than 0.0000001 mM of D-ornithine decarboxylate/min/mg |
649766 |
